23.36
Claritev Corp stock is traded at $23.36, with a volume of 151.16K.
It is down -6.71% in the last 24 hours and down -36.14% over the past month.
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The company's focus is on being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
See More
Previous Close:
$25.04
Open:
$24.29
24h Volume:
151.16K
Relative Volume:
1.18
Market Cap:
$395.89M
Revenue:
$978.76M
Net Income/Loss:
$-286.52M
P/E Ratio:
-1.3486
EPS:
-17.3212
Net Cash Flow:
$-31.63M
1W Performance:
-26.38%
1M Performance:
-36.14%
6M Performance:
+52.18%
1Y Performance:
-55.64%
Claritev Corp Stock (CTEV) Company Profile
Name
Claritev Corp
Sector
Industry
Phone
212-780-2000
Address
7900 TYSONS ONE PLACE, MCLEAN
Compare CTEV vs VEEV, TEM, BTSG, TXG, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
CTEV
Claritev Corp
|
23.36 | 395.89M | 978.76M | -286.52M | -31.63M | -17.32 |
|
VEEV
Veeva Systems Inc
|
274.84 | 44.50B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
TEM
Tempus Ai Inc
|
82.24 | 14.93B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
BTSG
Brightspring Health Services Inc
|
56.02 | 11.08B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TXG
10 X Genomics Inc
|
84.11 | 10.96B | 638.78M | -22.66M | 122.18M | -0.1744 |
|
HNGE
Hinge Health Inc
|
91.98 | 7.42B | 646.34M | -512.40M | 202.76M | -6.6871 |
Claritev Corp Stock (CTEV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-24-26 | Initiated | Barclays | Overweight |
| Jan-12-26 | Initiated | Guggenheim | Buy |
| Jan-09-26 | Initiated | Wells Fargo | Equal Weight |
| Oct-21-25 | Upgrade | Citigroup | Neutral → Buy |
| May-29-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jun-26-24 | Initiated | Piper Sandler | Neutral |
| Dec-13-22 | Downgrade | Citigroup | Buy → Neutral |
| Jul-12-22 | Initiated | Goldman | Neutral |
| Oct-04-21 | Resumed | Citigroup | Buy |
| Apr-07-21 | Initiated | B. Riley Securities | Buy |
| Mar-19-21 | Initiated | Barclays | Equal Weight |
View All
Claritev Corp Stock (CTEV) Latest News
Claritev Corporation (CTEV) Stock Price, News, Quote & History - Yahoo! Finance Canada
Douglas Michael Garis Sells 9,025 Shares of Claritev (NYSE:CTEV) Stock - MarketBeat
Claritev : Five Shifts Reshaping TPA Cost Management - marketscreener.com
Claritev (CTEV) CFO sells stock under pre-set plan - Stock Titan
CTEV Looks 10.5% Overvalued on GF Value™ - GuruFocus
Claritev Corporation Is Selected By General Dynamics Information Technology To Support CDC?s World Trade Center Health Program - marketscreener.com
Claritev Selected by GDIT to Support CDC’s World Trade Center Health Program - finance.yahoo.com
Planned Claritev (NYSE: CTEV) stock sale tops $278K - Stock Titan
Claritev (NYSE:CTEV) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Claritev Corp (CTEV) Stock Down 5.5% but Still Overvalued -- GF Score: 63/100 - GuruFocus
Claritev (NYSE:CTEV) Shares Down 4.3%Should You Sell? - MarketBeat
Claritev Releases 2025 Corporate Responsibility Report - finance.yahoo.com
New Claritev (CTEV) director gets 2,880-share RSU award - Stock Titan
Claritev (NYSE: CTEV) Appoints Ben Letham as Director to Strengthen Board with AI Expertise - Kalkine Media
Claritev at Morgan Stanley healthcare conference: turnaround gains pace - Investing.com
Form 8K Claritev Corp For: 15 September By Investing.com - Investing.com Australia
Claritev appoints Meta AI researcher Ben Letham to board - Investing.com
Claritev appoints Meta AI researcher Ben Letham to board By Investing.com - Investing.com UK
A Meta AI researcher joins Claritev’s board - Stock Titan
Claritev (NYSE:CTEV) Trading Up 4%Time to Buy? - MarketBeat
Claritev Cares Helps Rural Patients Get Critical Care Closer to Home - Stock Titan
Claritev’s (CTEV) Profit Picture Brightens, But Its Cash Cushion Shrinks - Yahoo Finance
Bank of America Corp DE Purchases 58,133 Shares of Claritev $CTEV - MarketBeat
Claritev (NYSE:CTEV) CEO Buys 4,500 Shares of Stock - MarketBeat
Claritev CEO Travis Dalton buys $249,663 in company stock By Investing.com - Investing.com South Africa
Claritev CEO Travis Dalton buys $249,663 in company stock - Investing.com
Travis Dalton Purchases 1,950 Shares of Claritev (NYSE:CTEV) Stock - MarketBeat
Claritev (CTEV) CEO adds 6,450 shares via spouse IRA - Stock Titan
Claritev Corporation Announces Participation in Upcoming Events - finance.yahoo.com
Is Claritev Corp (CTEV) Overvalued After 9.4% Rally? GF Value Sa - GuruFocus
CTEV Maintained by Barclays -- Price Target Raised to $40.00 - GuruFocus
Claritev (CTEV) Q2 2026 Earnings Call Transcript - AOL.com
Claritev (NYSE:CTEV) SVP Tiffani Misencik Sells 8,850 Shares - MarketBeat
Claritev Corp (CTEV) exec sells 8,850 shares, holds 123,723 - Stock Titan
Claritev (NYSE:CTEV) Shares Gap DownHere's Why - MarketBeat
Claritev Chief Growth Officer Tiffani Misencik sells 8,850 shares worth $354,592.95 - Bitget
Claritev says Marpai expands contract for pre- and post-payment claims integrity services - Bitget
CTEV Looks 33.2% Overvalued on GF Value™ - GuruFocus
Marpai expands Claritev agreement for payment integrity By Investing.com - Investing.com Australia
Marpai expands Claritev agreement for payment integrity - Investing.com
Marpai expands beyond network access—but what comes next? - Stock Titan
Marpai Expands Relationship With Claritev To Help Reduce Healthcare Costs For Employer Clients - TradingView
Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients - Business Wire
Claritev $CTEV Shares Sold by Renaissance Technologies LLC - MarketBeat
Claritev (NYSE:CTEV) Rating Increased to Hold at Zacks Research - MarketBeat
Claritev Corp SEC Filing (Aug 14, 2026) - Stock Titan
Claritev (NYSE:CTEV) Shares Down 5.1%Time to Sell? - MarketBeat
Have Insiders Sold Claritev Shares Recently? - simplywall.st
CTEV Q2 2026 Earnings: Narrower-Than-Expected Loss Sparks 19.5% RallyEarnings Per Share - dars.gov.et
Claritev (CTEV) Stock Fair Value Rises After Analysts Weigh Growth Against Leverage Risks - Yahoo Finance
Claritev (NYSE:CTEV) Stock Price Up 7.7% Following Analyst Upgrade - MarketBeat
Claritev Corp Stock (CTEV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):